1. Home
  2. SHO vs IOVA Comparison

SHO vs IOVA Comparison

Compare SHO & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

HOLD

Current Price

$11.48

Market Cap

1.8B

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.85

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHO
IOVA
Founded
1995
2007
Country
United States
United States
Employees
37
N/A
Industry
Hotels/Resorts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
SHO
IOVA
Price
$11.48
$3.85
Analyst Decision
Hold
Buy
Analyst Count
7
10
Target Price
$9.79
$9.00
AVG Volume (30 Days)
1.9M
12.1M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
3.66%
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.95
$47.74
Revenue Next Year
$2.30
$40.31
P/E Ratio
$966.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.43
$1.67
52 Week High
$11.71
$5.63

Technical Indicators

Market Signals
Indicator
SHO
IOVA
Relative Strength Index (RSI) 72.80 49.17
Support Level $8.81 $2.07
Resistance Level N/A $4.27
Average True Range (ATR) 0.24 0.37
MACD 0.04 -0.02
Stochastic Oscillator 82.71 34.15

Price Performance

Historical Comparison
SHO
IOVA

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: